A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK

Conditions: Alzheimer Disease; Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 1 (Disorder); Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 2 (Disorder); Autosomal Dominant Alzheimer Disease Due to Mutation of Amyloid Precursor Protein (Disorder) Interventions: Drug: NIO752; Other: Placebo Sponsors: University College, London; Washington University School of Medicine; University of Washington; Alzheimer ' s Association; Sigrid Rausing Trust Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials